Popular
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
Project Oncology®HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
Personalizing Care Within the RCC Treatment Paradigm
CME/CEPersonalizing Care Within the RCC Treatment Paradigm
Chairperson Perspective: Core Concepts for Community-Based Practice: The Evolving Role of Bispecific Antibody Therapy in Relapsed or Refractory Follicular Lymphoma
CME/CEChairperson Perspective: Core Concepts for Community-Based Practice: The Evolving Role of Bispecific Antibody Therapy in Relapsed or Refractory Follicular Lymphoma
The Alloimmune Disorders of Pregnancy: Optimizing Fetal Outcomes Through Advances in Diagnosis and Treatment
CME/CEThe Alloimmune Disorders of Pregnancy: Optimizing Fetal Outcomes Through Advances in Diagnosis and Treatment
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
MinuteCE®Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
Chairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
CME/CEChairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
New and Emerging PAH Therapies and Approaches: A Mixture of Hope and Complexity
CME/CE Live BroadcastNew and Emerging PAH Therapies and Approaches: A Mixture of Hope and Complexity
June 18, 2025
12:00 PM - 01:00 PM EDT
Antibody-Drug Conjugates in Bladder Cancer: Guideline Updates and Adverse Event Management
CME/CEAntibody-Drug Conjugates in Bladder Cancer: Guideline Updates and Adverse Event Management
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
MinuteCE®Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
MinuteCE®The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC
MinuteCE®Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC
Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
MinuteCE®Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
From Guidelines to Practice: First-Line Treatment Choices in mCRC
MinuteCE®From Guidelines to Practice: First-Line Treatment Choices in mCRC
CME/CE
- ADC Learning Center
- Advances in Chronic Kidney Disease
- Allergy, Asthma, and Immunology
- Amyloid Transthyretin (ATTR) Learning Center
- Bladder Health/Incontinence
- Breast Cancer and Breast Health
- Cardiology
- Cervical Cancer Screening
- Clinical Pharmacology
- Colorectal Cancer
- Critical Care
- Dermatology
- Diabetes
- Diabetes and Endocrinology
- Emergency Medicine
- Endocrinology
- Endometriosis
- Gastroenterology and Hepatology
- General Medicine and Primary Care
- Genetics
- Gynecologic Cancers
- Hospital Medicine
- Infectious Diseases
- Medical Device and Technology CME
- Mental Health
- Nephrology
- Neurology and Neurosurgery
- Nutrition
- Obesity
- Obstetrics
- Obstetrics and Gynecology
- Oncology and Hematology
- Ophthalmology
- Pathology and Laboratory Medicine
- Pediatrics
- Psychiatry and Mental Health
- Pulmonary Medicine
- Radiology
- Rare and Orphan Diseases
- Reproductive Endocrinology & Infertility
- Rheumatology
- Sleep Disorders
- Sleep Medicine
- Surgery
- Transplantation
- Urology
- Vascular Medicine
- Women's Health
- AXIS Medical Education
- Clinician’s Roundtable CME
- Fetal Fibronectin (fFN) and Preterm Labor
- GI Insights CME
- Global Liver Academy
- Global Neurology Academy
- Global Oncology Academy
- Global Women's Health Academy
- Medtelligence
- MinuteCE®
- Neuro Frontiers CME
- Omnia Education
- PACE-CME
- Project Oncology® CME
- Prova Education
- RMEI
- TotalCME
- The ARIA Toolkit
- Multidisciplinary Management of Extrahepatic Organ Failures in Patients with Advanced Liver Disease